Managed by Frazier Life Sciences Management, L.P. • Latest filing Q4 2025
Overlap peers will appear here as data populates
Related fund suggestions coming soon.
| — |
| 5 | N | $409.1M | 15.92M | 0.00% | — |
| 6 | V VRNA — | $361.1M | 3.38M | 0.00% | — |
| 7 | M MIRM — | $345.8M | 6.80M | 0.00% | — |
| 8 | N | $329.9M | 16.12M | 0.00% | — |
| 9 | V VRNA — | $320.1M | 3.38M | 0.00% | — |
| 10 | M MIRM — | $306.1M | 6.80M | 0.00% | — |
| 11 | N | $300.8M | 16.61M | 0.00% | — |
| 12 | N | $289.2M | 12.23M | 0.00% | — |
| 13 | A ARQT — | $286.8M | 9.87M | 0.00% | — |
| 14 | M MIRM — | $271.7M | 6.57M | 0.00% | — |
| 15 | B BBIO — | $271.2M | 3.55M | 0.00% | — |
| 16 | M MIRM — | $256.2M | 6.57M | 0.00% | — |
| 17 | N | $234.9M | 12.23M | 0.00% | — |
| 18 | M MIRM — | $222.1M | 6.50M | 0.00% | — |
| 19 | V VRNA — | $219.5M | 3.46M | 0.00% | — |
| 20 | N | $213.4M | 12.86M | 0.00% | — |